Main Menu

Our Work

Search Term:

  • Life Sciences
Clear All

Showing 13 - 24 of 65 results

  • Provided expert testimony on behalf of a medical device manufacturer in a products liability matter. Support included providing client with an analysis of liability, damages, and issues of causation, as well as assessing whether a proposed ...

  • In Swanston v. TAP Pharmaceutical Products, provided expert testimony on issues of predominance and feasible damages methodologies on behalf of a joint defense group of leading pharmaceutical manufacturers opposing class certification ...

  • Serving as lead consulting expert for the plaintiffs in a matter involving a pharmaceutical manufacturer that allegedly engaged in anticompetitive conduct resulting in the branded drug continuing to maintain majority market share despite ...

  • Since 2004, Bates White experts have analyzed the economic issues underlying Average Wholesale Price (AWP) claims. We have worked on behalf of numerous pharmaceutical companies in lawsuits that span a variety of jurisdictions and include ...

  • In United States ex rel. Steven May and Angela Radcliffe v. Purdue Pharma L.P., provided expert testimony on causation and damages on behalf of Purdue in connection with alleged False Claims Act (FCA) violations concerning alleged ...

  • In United States v. Guidant Corp., provided expert testimony on damages on behalf of a medical device manufacturer in connection with alleged FCA violations concerning certain implantable cardiac devices affected by a manufacturing ...

  • Served as consulting expert to evaluate issues of liability, causation, and damages on behalf of a major brand name drug manufacturer facing a government investigation into various allegations regarding its marketing practices. These ...

  • Retained to provide expert testimony on behalf of a specialty pharmacy in a matter involving allegations of Anti-Kickback Statute violations. 

  • Computed damages arising from lost sales of a major antiviral pharmaceutical product. The dispute alleged breach of contract, specifically through the failure to provide adequate marketing and promotional support. Developed but-for ...

  • Provided consulting expertise on issues of liability, causation, and damages on behalf of a pharmaceutical manufacturer alleged to have engaged in off-label marketing.

  • In response to changes to the regulatory requirements for reporting prices to Texas Medicaid’s Vendor Drug Program, collaborated with in-house and outside legal counsel to support a generic manufacturer in developing functional price ...

  • Prepared a report for a trade group representing research-based pharmaceutical and biotechnology companies that evaluated potential compliance costs resulting from new Affordable Care Act requirements related to the calculation of AMP.

Jump to Page